Campus Box 7469
Chapel Hill 27599-7469
Dr. Tilson received his Bachelor’s from Reed College, his MD from Washington University School of Medicine, and his MPH and DrPH from Harvard School of Public Health. He has served as Director of North Carolina’s Division of Health Services and was Vice President and Worldwide Director, Epidemiology, Surveillance & Policy Research at Glaxo Wellcome.
|Tilson, H, Novotny T (1997)
Publishing while Practicing: A Five-Step Guide for Academic-Practice Partners” with TE Novotny et al..
American Journal of Preventive Medicine: vol.13, p.10-11.
|Tilson, H, Kotsanos J (1997)
Development of Performance Measures for Seven Chronic Diseases.
The joint Commission Journal on Quality Improvement: vol.23, p.150-161.
|Tilson, H (1996)
Health Communities: New Partnerships for the Furture of Public Health (Preface).
Institute of Medicine, National Academy Press
|Tilson, H, Mauskoph J. (1996)
Economic Impact of Treatment of HIV-Positive Pregnant Women and their newborns with Zidovudine: Implications for HIV Screening.
JAMA: vol.276, p.132-138.
|Tilson, H, Hickey A (1996)
The Rheumatoid Arthritis Azathioprine Registry – an update”.
Advances in Anti-Rheumatic Therapy: vol.Chapter 9